Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.31B.
ENTERPRISE VALUE (EV)
$1.31B
Harrow Health, Inc.
Market Cap
$1.14B
Enterprise Value (EV)
$1.31B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Harrow Health, Inc. (HROW) | $1.14B | $1.31B |
| OPKO Health, Inc. (OPK)vs › | $1.14B | $1.23B |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | $1.39B |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | $1.59B |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.15B | $904.69M |
| Nektar Therapeutics (NKTR)vs › | $1.16B | $1.26B |
| Replimune Group, Inc. (REPL)vs › | $1.11B | $1.04B |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | $630.23M |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.10B | $1.00B |
| IRadimed Corporation (IRMD)vs › | $1.09B | $1.03B |
Market Cap
$1.14B
Total Debt
$244.07M
Cash
$72.93M
Enterprise Value
$1.31B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
